Louisiana State Employees Retirement System Takes $4.81 Million Position in Tenet Healthcare Corporation $THC

Louisiana State Employees Retirement System purchased a new position in Tenet Healthcare Corporation (NYSE:THC) during the 1st quarter, Holdings Channel.com reports. The firm purchased 25,500 shares of the company’s stock, valued at approximately $4,812,000.

Other institutional investors have also bought and sold shares of the company. Norges Bank purchased a new position in shares of Tenet Healthcare in the 4th quarter worth $248,494,000. Eminence Capital LP bought a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $225,263,000. Wellington Management Group LLP grew its position in Tenet Healthcare by 1,114.2% in the fourth quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after acquiring an additional 1,042,260 shares in the last quarter. Boston Partners increased its stake in Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after acquiring an additional 880,413 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in shares of Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after purchasing an additional 720,160 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on THC. Guggenheim cut their target price on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Robert W. Baird cut their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Stephens lowered their target price on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Finally, Wells Fargo & Company dropped their price target on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and an average target price of $244.32.

Tenet Healthcare Price Performance

THC opened at $187.64 on Friday. The business has a fifty day moving average of $181.14 and a 200 day moving average of $197.51. The stock has a market cap of $16.16 billion, a P/E ratio of 9.76, a PEG ratio of 1.51 and a beta of 1.28. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare Corporation will post 17.61 EPS for the current year.

Insider Activity

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the business’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.97% of the stock is owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.